Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01372462 · ClinicalTrials.gov registry record · NA

Effects of the Breathe Technologies Ventilation System in Subjects With Chronic Obstructive Pulmonary Disease

A NA study of Chronic Obstructive Pulmonary Disease, sponsored by Breathe Technologies.

Completed
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT01372462 is a NA study of Chronic Obstructive Pulmonary Disease that has completed, run by Breathe Technologies. The registered enrollment target is 15 participants, below the 1,754-participant average among 86 other Chronic Obstructive Pulmonary Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01372462, a NA study of Chronic Obstructive Pulmonary Disease, has completed, sponsored by Breathe Technologies.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

Pilot study in 15 stable male subjects with severe-to-very severe Chronic Obstructive Pulmonary Disease (COPD) to evaluate the effects of short term use of the Breathe Technologies noninvasive open ventilation (NIOV) system on respiratory mechanics during constant work rate exercise in subjects with severe COPD.

Interventions

  • DEVICE NIOV - Room Air
  • DEVICE NIOV - Oxygen
  • DEVICE Nasal Cannula Oxygen

Study Locations (1)

California

  • Harbor-UCLA Medical Center - Torrance

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2011-07
Est. Completion 2012-05
Phase NA

Sponsor

Breathe Technologies

4 total trials

What the Registry Record Tells You About NCT01372462

The ClinicalTrials.gov registry entry for NCT01372462 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,754-participant average among 86 other Chronic Obstructive Pulmonary Disease trials with a reported enrollment target (99% lower). The listed sponsor is Breathe Technologies, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Obstructive Pulmonary Disease appearing as the primary indexed condition, and to 3 interventions - of which NIOV - Room Air is the first listed.

NCT01372462 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT01372462 about?

NCT01372462 is a clinical study titled "Effects of the Breathe Technologies Ventilation System in Subjects With Chronic Obstructive Pulmonary Disease". Pilot study in 15 stable male subjects with severe-to-very severe Chronic Obstructive Pulmonary Disease (COPD) to evaluate the effects of short term use of the Breathe Technologies noninvasive open ventilation (NIOV) system on respiratory mechanics during constant work rate exercise in subjects with...

What is the current status of trial NCT01372462?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2011-07. Estimated completion is 2012-05.

What conditions does trial NCT01372462 study?

This clinical trial studies the following conditions: Chronic Obstructive Pulmonary Disease.

What interventions are being tested in trial NCT01372462?

The interventions under investigation include: NIOV - Room Air (DEVICE), NIOV - Oxygen (DEVICE), Nasal Cannula Oxygen (DEVICE).

Who is sponsoring clinical trial NCT01372462?

This trial is sponsored by Breathe Technologies, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01372462 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Obstructive Pulmonary Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.